Cullinan Oncology Inc (CGEM)
21.18
+0.06 +0.28%
NASDAQ
Oct 19, 11:52
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.372 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -53.91M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 922.20M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | -- |
| PE Ratio | -- |
| Price to Book Value | 2.024 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -16.20M |
| Return on Equity | Upgrade |
View All CGEM News
News
-
WireHeadlineTime (ET)
-
SA Breaking News10/18 17:54
-
MT Newswires10/18 17:05
-
SA Breaking News10/18 12:43
-
MT Newswires10/18 07:58
-
Yahoo10/18 07:00
-
MT Newswires09/21 16:39
-
MT Newswires09/20 17:35
-
MT Newswires09/16 16:55
-
MT Newswires09/09 07:53
-
MT Newswires09/08 16:24
-
Globe Newswire09/08 16:01
-
Yahoo08/16 06:44
-
MT Newswires08/10 06:30
-
Globe Newswire08/10 06:30
-
Globe Newswire08/05 16:05
-
SA Breaking News07/02 15:30
-
SA Breaking News06/29 08:44
-
Globe Newswire06/29 08:00
-
MT Newswires06/07 09:52
-
SA Breaking News06/07 08:48
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/15/2021 | Earnings Results | Q3 2021 Earnings Results |
| 08/10/2021 | Earnings Results | Q2 2021 Earnings Results |
| 06/25/2021 10:00 EST | AGM | 2021 Annual General Meeting |
| 05/14/2021 | Earnings Results | Q1 2021 Earnings Results |
| 03/30/2021 | Earnings Results | Q4 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
- URL: https://www.cullinanoncology.com
- Investor Relations URL: https://investors.cullinanoncology.com/
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: N/A
- Next Earnings Release: Nov. 15, 2021
- Last Earnings Release: Aug. 10, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 21.18 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CGEM Tweets Stocktwits
Advertisement
